Go to main content
 
DH endorses batch recall of APO-SERTRALINE Capsules 50mg (with photos)
**********************************************************************
     The Department of Health (DH) today (January 16) endorsed a licensed drug wholesaler, Hind Wing Co Ltd, to recall a batch (batch number MV1007) of APO-SERTRALINE Capsules 50mg (Hong Kong registration number HK-49970) from the market as the pharmaceutical product may actually contain APO-SERTRALINE Capsules 25mg, which are of lesser strength.

     The DH received notification from Hind Wing that the 50mg product's manufacturer in Canada was recalling the above batch as it may contain the 25mg product. According to the manufacturer, the causes of the issue are still under investigation but only one batch was affected. The DH's investigation is continuing.

     The 50mg product, containing sertraline, is a prescription medicine used for depression. According to Hind Wing, 95 bottles from the affected batch have been supplied to a dispensary of the DH (not yet dispensed), private doctors and local pharmacies.

     "So far, the DH has not received any adverse reaction reports in connection with the affected product," a spokesman for the DH said.

     Hind Wing has set up a hotline (2541 5731) to answer related enquiries. The DH will closely monitor the recall.

     People prescribed with the two products should check the capsule before consumption. The capsule of the 50mg product is yellow-white and printed with "APO" and "50", while that of the 25mg product is entirely yellow and printed with "APO" and "25". Members of the public should consult healthcare professionals if in doubt.
 
Ends/Monday, January 16, 2017
Issued at HKT 20:03
NNNN
Archives   Yesterday's Press Releases   Back to Index Page Back to top
Today's Press Releases  

Photo

The Department of Health today (January 16) endorsed a batch recall of APO-SERTRALINE Capsules 50mg as the product may contain APO-SERTRALINE Capsules 25mg.
The Department of Health today (January 16) endorsed a batch recall of APO-SERTRALINE Capsules 50mg. Photo shows a 50mg capsule, which is yellow-white and printed with "APO" and "50".
The Department of Health today (January 16) endorsed a batch recall of APO-SERTRALINE Capsules 50mg. Photo shows the 25mg capsule which is of lesser strength, entirely yellow and printed with "APO" and "25".